HPV cancer vaccine slows tumor growth and extends survival in preclinical model
medicalxpress - Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept across multiple studies, the…
AI Summary: A therapeutic HPV vaccine showed tumor shrinkage and longer survival in preclinical models of HPV‑driven oropharyngeal cancer, suggesting a possible adjunct to surgery and chemo‑radiation. Researchers say the approach could boost anti‑tumor immunity and inform next‑stage trials, though human efficacy and safety await clinical proof.
FDA clears 1st blood test for Alzheimer’s in primary care
Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …
AI Summary: Regulators cleared the first blood test for Alzheimer’s for primary‑care use while researchers published capillary sampling methods and analyses showing blood biomarkers’ promise for dementia diagnosis. Together these developments push biomarker testing out of specialty clinics and toward routine care — promising earlier detection, though concerns about population diversity, accuracy thresholds and rollout logistics remain.
Studies test whether gene-editing can fix high cholesterol. For now, take your medicine
medicalxpress - Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.
AI Summary: Researchers are testing gene‑editing approaches aimed at providing a single‑procedure solution for elevated LDL cholesterol. Early human studies probe safety and durability, but experts urge patients to continue proven lipid‑lowering therapies for now. The line between ambitious science and everyday clinical care remains prudently guarded.
FDA to reassess the safety of BHA, a preservative used in popular snack foods
go - Federal health officials will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products
AI Summary: U.S. regulators have moved to reevaluate butylated hydroxyanisole (BHA), a common food preservative, ordering a fresh safety review after mounting evidence and public concern. The reassessment could lead to updated guidance or restrictions — which will delight activists and mildly inconvenience snack manufacturers.
Report reveals a significant global palliative care gap among children
medicalxpress - Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, according to a comprehensive new r…
AI Summary: A new global analysis reveals roughly 10.6 million children live with serious health‑related suffering and face a striking lack of pediatric palliative services, especially in low‑ and middle‑income countries. The study calls for urgent policy, training and resource commitments to close the gap and reduce needless pain for sick children — because saying “we’ll do better” is no longer enough.
Ama launches independent vaccine review after CDC criticism
medicalxpress - Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.
AI Summary: The American Medical Association announced an independent review of vaccine safety and effectiveness in response to recent CDC changes and criticism, partnering with external researchers to evaluate evidence and restore public trust. The panel aims to provide transparent, expert analysis free of political noise.
Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group
Katie Adams / medcitynews - Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving…
AI Summary: Talkiatry closed a $210 million Series D led by Perceptive Advisors to scale its virtual psychiatry platform, expanding telepsychiatry access and accelerating growth plans. The financing positions the company to beef up operations, hire talent, and deepen partnerships as demand for remote mental health care surges.
AbbVie sues over selection of Botox for IRA negotiations
Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...
AI Summary: AbbVie has filed suit challenging the federal decision to include Botox in Medicare’s drug price negotiation program, arguing the selection process was flawed and that the move could imperil innovation and pricing strategies. The lawsuit seeks to block or alter implementation while the industry and regulators brace for legal precedent.
Kaiser Permanente, DoL reach settlement over mental health access
fiercehealthcare - Kaiser Foundation Health Plan has agreed to a settlement with the Department of Labor that resolves multiple investigations into access for mental health and substance abuse services.
AI Summary: Kaiser Foundation Health Plan reached a settlement with the U.S. Department of Labor resolving investigations into alleged failures to provide adequate mental‑health access. The move comes amid rolling labor actions at Kaiser — pharmacy and lab employees briefly struck and later stood down while nurse‑led walkouts continued — exposing labor tensions and regulatory pressure.
Thousands of NYC nurses return to work, but one major strike goes on
medicalxpress - A monthlong nurses strike in New York City is coming to an end, but not for everyone.
AI Summary: After weeks of labor turmoil, most striking New York City nurses have tentatively returned under new agreements, but a substantial contingent at a major hospital remains on strike. Patients and families report care disruptions and uncertainty as remaining negotiations continue, highlighting strain on hospitals and lingering tensions between staff and management.
500M records exchanged through TEFCA, federal health IT office boasts
fiercehealthcare - At the 2026 Annual Meeting for the health IT office at HHS, officials announced a massive spike in the number of health records shared through the government-backed TEFCA initiative. The number seems to reflect the heavy focus Trump's HHS has put on digit…
AI Summary: The federal Trusted Exchange Framework and Common Agreement (TEFCA) has passed roughly 500 million health records exchanged across participating networks, a milestone officials say will accelerate interoperability and data flow. The milestone spotlights rapid uptake and complementary data initiatives—plus the governance and privacy work that now comes with scale.
Federal judge blocks $602M in CDC cuts to 4 states
Kelly Gooch / beckershospitalreview - A federal judge in the Northern District of Illinois granted a temporary restraining order Feb. 12 blocking the Trump administration from terminating more than $600 million in CDC-administered public health grants to California, Colorado, Illinois and Min…
AI Summary: A federal judge issued a temporary restraining order halting the administration’s planned termination of roughly $600M in CDC grants to several states, siding with lawsuits that argued the cuts would impair public-health programs. The order preserves funding while courts consider claims that the move would cause immediate harm.
FDA refuses to review Moderna flu vaccine
Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …
AI Summary: Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making.
Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide
Charles Z. Levkoe, Canada Research Chair in Equitable and Sustainable Food Systems, Lakehead Univers / theconversation - The recent retraction of peer-reviewed research claiming glyphosate is safe confirms what Indigenous communities have said for years.
AI Summary: The recent retraction of a widely cited study asserting glyphosate’s safety has rekindled long‑held Indigenous suspicions about the herbicide. Experts now question its safety profile, calling for more regulatory scrutiny and a re‐evaluation of long‑standing warnings regarding its potential dangers.
Public Health Department confirms first 2026 measles case in Los Angeles County
medicalxpress - The Department of Public Health has confirmed the first measles case this year in Los Angeles County. Officials say the person who tested positive for measles had recently traveled outside the country. The department is now working to identify people who …
AI Summary: Los Angeles County health officials confirmed the first measles case of 2026 even as nationwide data reveal that only one month into the year, case numbers have already reached 25% of 2025’s total. Experts warn that if vaccination rates do not improve promptly, an early outbreak could expand and stress public health systems.
World Cancer Day: A Global Call to Awareness and Action 2026, Part 2
oncodaily - World Cancer Day is observed annually on February 4 and was established in 2000 at the World Summit Against Cancer for the New Millennium in Paris. The initiative was led […]
AI Summary: World Cancer Day 2026, observed on February 4, serves as a global rallying cry to boost cancer awareness, promote early detection, and improve patient access to care. Healthcare professionals, advocates, and patients united at the event to spotlight the critical need for innovation and coordinated action against cancer.
- Early Detection & Access Initiatives (4)
- Other Cancer News (15)
- Research and Treatment Advances (28)
- World Cancer Day Global Events (4)
- All Other Stories
Early Detection & Access Initiatives
Other Cancer News
Research and Treatment Advances
World Cancer Day Global Events
All Other Stories
HHS launches $100M homelessness, addiction treatment initiative
Ella Ruder / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. unveiled a $100 million federal initiative to address homelessness, opioid addiction and public safety following President Donald Trump’s executive order creating the Great American Recovery Initiative. The Safety Throu…
AI Summary: Two nearly identical reports detail a new federal announcement by HHS, which unveiled a $100M initiative aimed at tackling homelessness among individuals with addiction issues. The program is designed to integrate mental health, addiction treatment, and social services to rapidly stabilize vulnerable populations.
MultiCare agrees to $3.7M settlement over allegations it knowingly allowed unnecessary surgeries
fiercehealthcare - The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.
AI Summary: Federal investigators found that MultiCare knowingly allowed a former physician to perform unnecessary spinal surgeries despite multiple warnings, prompting a whistleblower lawsuit. In response, the health system agreed to a $3.7 million settlement to resolve the allegations and avoid further litigation.
HHS to drop 340B rebate pilot after court rulings
Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…
AI Summary: In a twist that no one saw coming (except the federal courts), HHS has scrapped its controversial 340B rebate pilot after two judicial rulings blocked its implementation. Providers, relieved to avoid a potential cash flow nightmare, are quietly celebrating the decision as one less bureaucratic headache to manage.
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Ayisha Sharma / endpoints - Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention. The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...
AI Summary: Bayer’s latest Phase 3 study of asundexian has shown a 26% reduction in secondary ischemic stroke risk—without an increased bleeding risk. This compelling data bolsters the drug’s prospects as a blockbuster in stroke prevention and underscores Bayer’s commitment to advancing cardiovascular therapies.